American Renal Associates (ARA) Tops Q2 EPS by 3c

American Renal Associates (NYSE: ARA) reported Q2 EPS of $0.20, $0.03 better than the analyst estimate of $0.17. Revenue for the quarter came in at $217.2 million versus the consensus estimate of $204.01 million.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c